HER2/neu gene amplification determines the sensitivity of uterine serous carcinoma cell lines to AZD8055, a novel dual mTORC1/2 inhibitor
- Resource Type
- Article
- Source
- In
Gynecologic Oncology December 2013 131(3):753-758 - Subject
- Language
- ISSN
- 0090-8258